CCB = Calcium channel blockers; CSR = Cochrane systematic review; *
Systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥110
mmHg; † respiratory distress syndrome, bronchopulmonary dysplasia,
retinopathy of prematurity, necrotizing enterocolitis, intraventricular
hemorrhage grade 3 or 4, hypoglycemia, bradycardia, seizure,
hypotension.
References
- Ananth CV, Duzyj CM, Yadava S, Schwebel M, Tita ATN, Joseph KS.
Changes in the prevalence of chronic hypertension in pregnancy, United
States, 1970 to 2010. Hypertension 2019; 74: 1089-95.
- American College of Obstetricians and Gynecologists’ Committee on
Practice Bulletins — Obstetrics. ACOG practice bulletin no. 203:
chronic hypertension in pregnancy. Obstet Gynecol 2019;
133(1):e26-e50.
- Tita AT, Szychowski JM, Boggess K, et al. Chronic Hypertension and
Pregnancy (CHAP) Trial Consortium. Treatment for Mild Chronic
Hypertension during Pregnancy. N Engl J Med. 2022;386:1781-1792.
- Abalos_E, Duley_L, Steyn_DW, Gialdini_C. Antihypertensive drug
therapy for mild to moderate hypertension during pregnancy. Cochrane
Database of Syst Rev 2018;10:CD002252.
- Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight
control of hypertension in pregnancy. N Engl J Med 2015; 372: 407-17.